MSD
This role is for a Senior Specialist in Method Transfers within the EU/APAC network, focusing on coordinating and executing large molecule analytical method transfers across R&D and QC laboratories. The incumbent will act as a key subject-matter expert to drive robust early-phase method development, ensuring right-first-time implementation at receiving sites while collaborating across cross-functional teams.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD didn’t post a salary, so this is our estimate from similar listings.
29% below the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Method Development, Validation & Transfer
Orca Bio
Senior QC Analyst, Method Development and Validation
Croda
Analyst III, Method Transfer Services (Biochemistry)
Emergent BioSolutions
Analytical Development Lead
Relay Therapeutics
QC Manager – Pharmaceutical Industry
Premier Service
Analyst II, Method Transfer Sciences (Biochemistry)
Emergent BioSolutions